🔗 Share this article Social Media Content Creators Driving Parallel Market for Unlicensed Slimming Medication A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations. Experimental Drug Gaining Traction Online Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers. Thriving Trade on Messaging Platforms Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases. Learning About Retatrutide Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic. Healthcare Experts Voice Worries However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users administering products of uncertain source. Several professionals said the demand for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro. Regulatory Position and Enforcement Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment. Service Response and Content Removal Based on TikTok, the service has removed violative material and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures. Digital Marketplace Operations Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at home. After minutes of joining one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or previous experience. Product Information and Pricing Within these groups, posts show black plastic parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.” Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”. Service Moderation and Security Actions A spokesperson for Telegram said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”. Healthcare Expert Cautions “People are administering substances they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said. Her staff has already seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.” Manufacturer Statement A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to possibly significant health risks”.